Evommune, Inc. · NYSE:EVMN
Carver Kyle bought 1,000 Evommune, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Carver Kyle (Chief Financial Officer) bought 1,000 Evommune, Inc. shares at US$13.26 for US$13,260, leaving 60,335 shares. Filed Jul 10, 2026 (Form 4).
- Bought
- 1,000 shares
- Price
- US$13.26
- Value
- US$13,260
- Holding after
- 60,335 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Buy | 1,000 | US$13.26 | 60,335 | Direct |
Source
Related
- Evommune, Inc.
- Carver Kyle
- Evommune, Inc. shareholders
- Form 4 · Carver Kyle · Jun 1, 2026
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026